Fuller & Thaler Asset Management’s Charles River Laboratories CRL Stock Holding History

Fuller & Thaler Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-449,901	Closed	-$70.4M	–	512
2025 Q3	$70.4M	Buy	449,901 +4,093	+0.9%	+$650K	0.24%	152
2025 Q2	$67.6M	Buy	+445,808	New	+$59.4M	0.25%	147
2022 Q1	–	Sell	-72	Closed	-$27K	–	493
2021 Q4	$27K	Hold	72	–	–	﹤0.01%	476
2021 Q3	$30K	Hold	72	–	–	﹤0.01%	455
2021 Q2	$27K	Sell	72 -80	-53%	-$26.7K	﹤0.01%	457
2021 Q1	$44K	Hold	152	–	–	﹤0.01%	456
2020 Q4	$38K	Hold	152	–	–	﹤0.01%	452
2020 Q3	$34K	Hold	152	–	–	﹤0.01%	454
2020 Q2	$27K	Hold	152	–	–	﹤0.01%	442
2020 Q1	$19K	Sell	152 -3	-2%	-$450	﹤0.01%	439
2019 Q4	$24K	Hold	155	–	–	﹤0.01%	425
2019 Q3	$21K	Hold	155	–	–	﹤0.01%	433
2019 Q2	$22K	Hold	155	–	–	﹤0.01%	422
2019 Q1	$23K	Hold	155	–	–	﹤0.01%	403
2018 Q4	$18K	Hold	155	–	–	﹤0.01%	413
2018 Q3	$21K	Hold	155	–	–	﹤0.01%	399
2018 Q2	$17K	Hold	155	–	–	﹤0.01%	728
2018 Q1	$17K	Buy	+155	New	+$16.7K	﹤0.01%	725
2016 Q1	–	Sell	-500	Closed	-$40K	–	783
2015 Q4	$40K	Hold	500	–	–	﹤0.01%	667
2015 Q3	$32K	Buy	+500	New	+$35.9K	﹤0.01%	618

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Fuller & Thaler Asset Management's CRL Position: Q4 2025 in Review

Fuller & Thaler Asset Management sold out of Charles River Laboratories (CRL) in Q4 2025, closing a stake of 449,901 shares — an estimated $70.4M sold.

Fuller & Thaler Asset Management first reported a position in CRL in Q3 2015 and held it in 20 quarters. The position peaked at $70.4M in Q3 2025. 580 funds tracked by Wall St. Rank hold CRL as of Q4 2025.

Fuller & Thaler Asset Management reported no remaining Charles River Laboratories position as of Q4 2025 after selling out during the quarter.
Fuller & Thaler Asset Management sold 449,901 Charles River Laboratories shares in Q4 2025, an estimated $70.4M.
Fuller & Thaler Asset Management first reported a position in Charles River Laboratories in Q3 2015 and held it in 20 quarters.
Fuller & Thaler Asset Management's Charles River Laboratories position peaked at $70.4M in Q3 2025.
580 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2025.

Based on Fuller & Thaler Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.